Education
About Us
Working with TipRanks
Follow Us
Treatment.com International (TSE:TRUE)
:TRUE
RESEARCH TOOLSreports
Total Valuation
Treatment.com International has a market cap or net worth of $26.43M. The enterprise value is ―.
Market Cap$26.43M
Enterprise Value―
Share Statistics
Treatment.com International has 75,502,396 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding75,502,396
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Treatment.com International’s return on equity (ROE) is 5.04 and return on invested capital (ROIC) is 750.88%.
Return on Equity (ROE)5.04
Return on Assets (ROA)-5.03
Return on Invested Capital (ROIC)750.88%
Return on Capital Employed (ROCE)3.15
Revenue Per Employee0.00
Profits Per Employee-1.24M
Employee Count3
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Treatment.com International is -1.64. Treatment.com International’s PEG ratio is -0.12.
PE Ratio-1.64
PS Ratio0.00
PB Ratio63.94
Price to Fair Value-8.26
Price to FCF-4.83
Price to Operating Cash Flow-5.00
PEG Ratio-0.12
Income Statement
In the last 12 months, Treatment.com International had revenue of 0.00 and earned -3.72M in profits. Earnings per share was -0.26.
Revenue0.00
Gross Profit0.00
Operating Income-2.33M
Pretax Income-3.72M
Net Income-3.72M
EBITDA-3.65M
Earnings Per Share (EPS)-0.26
Cash Flow
In the last 12 months, operating cash flow was -4.13M and capital expenditures 3.00, giving a free cash flow of -4.13M billion.
Operating Cash Flow-4.13M
Free Cash Flow-4.13M
Free Cash Flow per Share-0.05
Dividends & Yields
Treatment.com International pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-1.74
52-Week Price Change3.95%
50-Day Moving Average0.40
200-Day Moving Average0.56
Relative Strength Index (RSI)38.46
Average Volume (3m)126.06K
Important Dates
Treatment.com International upcoming earnings date is Aug 27, 2025, TBA Not Confirmed.
Last Earnings DateMay 30, 2025
Next Earnings DateAug 27, 2025
Ex-Dividend Date―
Financial Position
Treatment.com International as a current ratio of 0.50, with Debt / Equity ratio of 39.39%
Current Ratio0.50
Quick Ratio0.50
Debt to Market Cap0.07
Net Debt to EBITDA0.07
Interest Coverage Ratio-30.65
Taxes
In the past 12 months, Treatment.com International has paid -167.90K in taxes.
Income Tax-167.90K
Effective Tax Rate0.05
Enterprise Valuation
Treatment.com International EV to EBITDA ratio is -1.60, with an EV/FCF ratio of -7.87.
EV to Sales0.00
EV to EBITDA-1.60
EV to Free Cash Flow-7.87
EV to Operating Cash Flow-7.87
Balance Sheet
Treatment.com International has $230.70K in cash and marketable securities with C$127.17K in debt, giving a net cash position of -$103.53K billion.
Cash & Marketable Securities$230.70K
Total DebtC$127.17K
Net Cash-$103.53K
Net Cash Per Share>-$0.01
Tangible Book Value Per Share-$0.05
Margins
Gross margin is 100.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin100.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Treatment.com International is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-171.18%
EPS Growth Forecast46.80%